1-4 of 4
Yuanyuan Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Application of Next Generation Sequencing for Prognostic Stratification in Myelodysplastic Syndromes

Yuanyuan Xu, Yan Li, Guangyuan Hou, Chongjian Chen, Li Yu
Journal: Blood
Blood (2016) 128 (22): 5559.
https://doi.org/10.1182/blood.V128.22.5559.5559
Published: 2016
Journal Articles

TGF-β Receptor Kinase Inhibitor LY2109761 Reverses the Anti-Apoptotic Effects of TGF-β1 in Leukemic Cells Co-Cultured with Stromal Cells.

Yoko Tabe, MD, PhD, Yuanyuan Xu, BA, Teresa McQueen, BS, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2846.
https://doi.org/10.1182/blood.V110.11.2846.2846
Published: 2007
Journal Articles

Bone Marrow Stroma-Produced TGF-beta1 Confers Chemoresistance of Leukemic Cells.

Yoko Tabe, MD, PhD, Yuanyuan Xu, Linhua Jin, M.D., Ph.D., Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4248.
https://doi.org/10.1182/blood.V108.11.4248.4248
Published: 2006
Journal Articles

Bone Marrow Stromal Cells Modulate Sensitivity of CXCR4-Deficient CML Cells to Pharmacological Inhibitors of PI3K/AKT Signaling.

Linhua Jin, Yoko Tabe, MD, PhD, Nobuko Tanaka, Yuanyuan Xu, Atsushi Kato, Hagop Kantarjian, MD, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 4888.
https://doi.org/10.1182/blood.V106.11.4888.4888
Published: 2005